Markets › United States › NAS › BEAM

Beam Therapeutics Inc

NAS:BEAMHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$24.93+3.06%At closeAt close · Wed 21 Oct · ≈ AED 91.56 · Market cap $2.57B · Next earnings Tue 3 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−429,812.5%	−347.8%	−411.5%	100.0%	−478.7%	84.0%	—	—
Operating margin	−553,166.7%	−757.0%	−555.6%	−46.7%	−654.3%	−274.6%	−274.6%	+0.0 pts
Net margin	−810,800.0%	−714.9%	−474.5%	−35.1%	−593.1%	−57.2%	−57.2%	+0.0 pts
EBITDA margin	−533,437.5%	−443.8%	−445.7%	−26.9%	−558.5%	−21.4%	—	—
Return on equity	−79.2%	−44.8%	−39.4%	−13.5%	−51.4%	−6.5%	−6.5%	+0.0 pts
Return on assets	−43.1%	−25.1%	−21.5%	−9.1%	−34.1%	−5.4%	−5.4%	+0.0 pts
Return on capital employed	−38.0%	−31.1%	−30.3%	−14.1%	−45.1%	−27.7%	—	—
Debt / equity	0.4×	0.2×	0.2×	0.2×	0.2×	0.2×	0.2×	+0.0%
Debt / assets	23.8%	10.0%	13.3%	11.8%	14.6%	19.8%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	−8.8×	—	—
Current ratio	3.0×	6.0×	4.9×	5.9×	4.8×	13.1×	13.1×	+0.0%
Quick ratio	3.0×	6.0×	4.9×	5.9×	4.8×	13.1×	—	—
Cash ratio	1.6×	2.6×	1.0×	2.1×	1.5×	3.0×	3.0×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.3×	0.1×	0.1×	—	—
Receivables turnover	—	0.2×	—	—	—	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—